Private Healthcare: The Competition Commission Launches an Investigation
In response to rising costs and concerns about transparency, the Competition Commission has initiated an investigation into the private healthcare market in Mauritius.
The private healthcare sector in Mauritius is now under scrutiny by the Competition Commission. In a statement released on Friday, April 24, the institution announced the launch of a detailed investigation into the workings of this sector, marking the first of its kind under the new provisions of competition law. This initiative comes amid significant increases in medical costs, which are increasingly burdening households and raising questions about the transparency and fairness of the system.
According to Vipin Naugah, this move is essential given the rapid evolution of the sector. "The demand for private healthcare has significantly increased over the past decade, with annual spending currently estimated at around Rs 19 billion. The majority of this spending comes directly from household pockets, with a smaller proportion from medical insurance," he explains.
However, this expansion raises concerns. "We are witnessing a significant increase in the costs of care, coupled with transparency issues surrounding prices and the performance of private clinics," emphasizes Vipin Naugah. In this context, the Competition Commission believes that there are elements that could harm healthy competition, directly impacting patients in terms of costs and choices.
The investigation aims to thoroughly analyze the market structure, including concentration levels and the power dynamics among different players. According to the Commission, imbalances in negotiating power could contribute to maintaining high rates. Access to information is also a central issue, with patients often lacking the necessary elements to compare prices or assess the quality of services.
Another aspect under scrutiny is the referral practices among healthcare professionals. The Commission questions the potential existence of financial incentives that may influence medical decisions, risking over-treatment or directing patients to specific providers. If proven, these practices could have significant ethical implications and affect public trust in the healthcare system.
The role of insurance companies is also under examination. Preferred provider networks established by some insurers could limit patients' access to certain clinics, particularly smaller ones. Such a setup could restrict competition and reduce the diversity of offerings available in the market.
